HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 176 filers reported holding HERON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,014,240 | -11.8% | 6,809,942 | -0.7% | 0.00% | 0.0% |
| Q2 2023 | $7,952,509 | -25.7% | 6,855,611 | -3.3% | 0.00% | 0.0% |
| Q1 2023 | $10,701,000 | +63272.0% | 7,086,791 | +4.9% | 0.00% | -50.0% |
| Q4 2022 | $16,886 | -99.9% | 6,753,999 | +0.9% | 0.00% | -50.0% |
| Q3 2022 | $28,251,000 | +47.1% | 6,694,684 | -2.8% | 0.00% | +33.3% |
| Q2 2022 | $19,211,000 | -45.2% | 6,885,677 | +12.4% | 0.00% | -25.0% |
| Q1 2022 | $35,042,000 | -38.6% | 6,126,136 | -2.1% | 0.00% | -42.9% |
| Q4 2021 | $57,105,000 | +0.8% | 6,254,766 | +18.0% | 0.01% | 0.0% |
| Q3 2021 | $56,676,000 | -19.0% | 5,301,797 | +17.6% | 0.01% | -12.5% |
| Q2 2021 | $69,997,000 | +31.9% | 4,510,102 | +37.8% | 0.01% | +14.3% |
| Q1 2021 | $53,058,000 | -19.2% | 3,273,121 | +5.6% | 0.01% | -30.0% |
| Q4 2020 | $65,628,000 | +48.5% | 3,100,782 | +4.1% | 0.01% | +42.9% |
| Q3 2020 | $44,202,000 | +5.9% | 2,978,595 | +5.0% | 0.01% | -12.5% |
| Q2 2020 | $41,739,000 | +37.9% | 2,837,407 | +10.1% | 0.01% | +14.3% |
| Q1 2020 | $30,262,000 | -36.3% | 2,577,742 | +27.5% | 0.01% | -22.2% |
| Q4 2019 | $47,522,000 | +67.3% | 2,022,202 | +31.7% | 0.01% | +50.0% |
| Q3 2019 | $28,409,000 | +8.1% | 1,535,709 | +7.7% | 0.01% | +20.0% |
| Q2 2019 | $26,274,000 | +20.8% | 1,425,517 | +60.2% | 0.01% | +25.0% |
| Q1 2019 | $21,744,000 | +294.7% | 889,696 | +319.0% | 0.00% | +300.0% |
| Q4 2018 | $5,509,000 | -15.8% | 212,342 | +2.7% | 0.00% | 0.0% |
| Q3 2018 | $6,545,000 | -22.4% | 206,802 | -4.7% | 0.00% | -50.0% |
| Q2 2018 | $8,432,000 | +25.8% | 217,064 | -10.6% | 0.00% | +100.0% |
| Q1 2018 | $6,701,000 | +29.8% | 242,811 | -14.9% | 0.00% | 0.0% |
| Q4 2017 | $5,163,000 | +14651.4% | 285,208 | +12817.0% | 0.00% | – |
| Q3 2017 | $35,000 | +25.0% | 2,208 | +8.0% | 0.00% | – |
| Q2 2017 | $28,000 | -97.3% | 2,044 | -97.1% | 0.00% | – |
| Q1 2017 | $1,041,000 | +17.8% | 69,352 | +2.8% | 0.00% | – |
| Q4 2016 | $884,000 | -21.2% | 67,455 | +3.6% | 0.00% | – |
| Q3 2016 | $1,122,000 | -81.5% | 65,092 | -80.7% | 0.00% | -100.0% |
| Q2 2016 | $6,079,000 | -8.2% | 336,888 | -3.4% | 0.00% | 0.0% |
| Q1 2016 | $6,622,000 | -24.6% | 348,685 | +6.0% | 0.00% | 0.0% |
| Q4 2015 | $8,783,000 | +108.5% | 328,948 | +90.5% | 0.00% | +100.0% |
| Q3 2015 | $4,213,000 | +2293.8% | 172,689 | +888.5% | 0.00% | – |
| Q4 2014 | $176,000 | – | 17,469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |